Literature DB >> 28493517

Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma.

Joji Shimono1,2, Hiroaki Miyoshi1, Junichi Kiyasu3, Kensaku Sato1, Tomohiko Kamimura4, Tetsuya Eto5, Takuto Miyagishima6, Koji Nagafuji7, Takanori Teshima2, Koichi Ohshima1.   

Abstract

Splenic infiltration is often seen in diffuse large B-cell lymphoma (DLBCL). However, primary splenic DLBCL is rare and studies on its clinicopathological features are limited. We assessed 66 cases of primary splenic DLBCL and 309 control DLBCL, not otherwise specified. Hepatitis C virus antibody prevalence, B symptoms, poor performance status and CD5 positivity differed significantly between the primary splenic DLBCL and control DLBCL groups. Primary splenic DLBCL cases were classified histopathologically into two groups [white pulp pattern (n = 46), red pulp pattern (n = 20)]. Survival analysis showed no difference in overall survival between the primary splenic DLBCL and the control group, but the former had a more favourable progression-free survival. In the examination of primary splenic DLBCL, the white pulp pattern was statistically associated with a lower performance status (2-4), and a lower CD5 positivity than the red pulp pattern. In the survival analysis, the red pulp pattern demonstrated poorer overall survival. Multivariate analysis of overall survival in primary splenic DLBCL cases identified CD5 positivity as an indicator of poor prognosis. Classifying primary splenic DLBCL into white and red pulp patterns was useful in terms of clinicopathological features and overall survival.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  diffuse large B-cell lymphoma; hepatitis C virus; splenic lymphoma

Mesh:

Substances:

Year:  2017        PMID: 28493517     DOI: 10.1111/bjh.14736

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Acute pancreatitis as an unusual presentation of primary splenic lymphoma.

Authors:  Elisa Gravito-Soares; Marta Gravito-Soares; José Eduardo Pina-Cabral; Luis Tomé
Journal:  BMJ Case Rep       Date:  2017-10-10

2.  Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report.

Authors:  Sawsan Ismail; Filip Ali; Hussein Ajamieh; Samir Kanaan; Rana Issa; Ali Daoud; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2021-05-06

3.  Successful Treatment of Gastrosplenic Fistula Arising from Diffuse Large B-Cell Lymphoma with Chemotherapy: Two Case Reports.

Authors:  Makoto Saito; Kencho Miyashita; Yosuke Miura; Shinpei Harada; Reiki Ogasawara; Koh Izumiyama; Akio Mori; Masanori Tanaka; Masanobu Morioka; Takeshi Kondo
Journal:  Case Rep Oncol       Date:  2019-05-23

4.  Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years.

Authors:  Kosei Matsue; Yoshiaki Abe; Kentaro Narita; Hiroki Kobayashi; Akihiro Kitadate; Masami Takeuchi; Daisuke Miura; Kengo Takeuchi
Journal:  Br J Haematol       Date:  2019-07-03       Impact factor: 6.998

Review 5.  How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen.

Authors:  José Cabeçadas; Victor E Nava; Joao L Ascensao; Maria Gomes da Silva
Journal:  Curr Oncol       Date:  2021-11-11       Impact factor: 3.677

6.  Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.

Authors:  Yanna Lei; Qian Huang; Xiaoying Li; Xiufeng Zheng; Ming Liu
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.